Arkolith/Insider Trading/CCCC/Form 4

Adams Kendra

Chief Financial OfficerC4 Therapeutics, Inc. (CCCC) · full profile →Form 4 · filed Feb 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Tax withholding(F)5K$3.18$14K165K
Feb 14, 2025Grant(A)87K—$0170K
Feb 13, 2025Tax withholding(F)2K$3.20$6K83K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2025Grant(A)131K—$0131K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001662579-25-000016) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML